IL10 and myeloid sarcoma: In MS, increased expression of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin-4 (IL-4), and decreased expression of interleukin-10 (IL-10) have been confirmed [79,80].